CME Group Inc. $CME Shares Bought by Huntington National Bank

Huntington National Bank raised its position in CME Group Inc. (NASDAQ:CME) by 11.0% during the 2nd quarter, Holdings Channel reports. The firm owned 4,353 shares of the financial services provider’s stock after acquiring an additional 430 shares during the quarter. Huntington National Bank’s holdings in CME Group were worth $1,200,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of CME. OneDigital Investment Advisors LLC grew its holdings in CME Group by 18.2% in the first quarter. OneDigital Investment Advisors LLC now owns 2,937 shares of the financial services provider’s stock valued at $779,000 after purchasing an additional 452 shares during the last quarter. Wayfinding Financial LLC acquired a new stake in CME Group in the first quarter valued at $25,000. Penserra Capital Management LLC boosted its stake in shares of CME Group by 108.1% during the first quarter. Penserra Capital Management LLC now owns 5,343 shares of the financial services provider’s stock valued at $1,416,000 after acquiring an additional 2,776 shares during the last quarter. Envestnet Asset Management Inc. boosted its stake in shares of CME Group by 3.3% during the first quarter. Envestnet Asset Management Inc. now owns 570,206 shares of the financial services provider’s stock valued at $151,270,000 after acquiring an additional 18,098 shares during the last quarter. Finally, Financial Counselors Inc. boosted its stake in shares of CME Group by 12.2% during the first quarter. Financial Counselors Inc. now owns 4,245 shares of the financial services provider’s stock valued at $1,126,000 after acquiring an additional 461 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Wall Street Analysts Forecast Growth

CME has been the topic of a number of analyst reports. Raymond James Financial decreased their price objective on CME Group from $309.00 to $307.00 and set an “outperform” rating on the stock in a research note on Monday, October 13th. Deutsche Bank Aktiengesellschaft raised CME Group from a “hold” rating to a “buy” rating and increased their price objective for the company from $266.00 to $300.00 in a research note on Thursday, October 23rd. Citigroup raised CME Group from a “neutral” rating to a “buy” rating and increased their price objective for the company from $275.00 to $300.00 in a research note on Thursday, September 25th. Wall Street Zen lowered CME Group from a “hold” rating to a “sell” rating in a research note on Sunday, July 13th. Finally, JPMorgan Chase & Co. increased their price objective on CME Group from $252.00 to $256.00 and gave the company an “underweight” rating in a research note on Tuesday, October 14th. Eight analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat, CME Group presently has an average rating of “Hold” and an average price target of $285.19.

Insiders Place Their Bets

In other news, Director William R. Shepard acquired 262 shares of CME Group stock in a transaction dated Thursday, September 25th. The shares were acquired at an average cost of $265.19 per share, with a total value of $69,479.78. Following the purchase, the director directly owned 258,459 shares of the company’s stock, valued at approximately $68,540,742.21. This trade represents a 0.10% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Sunil Cutinho sold 11,896 shares of CME Group stock in a transaction dated Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total value of $3,229,407.12. Following the completion of the transaction, the insider directly owned 17,440 shares in the company, valued at $4,734,436.80. This represents a 40.55% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 14,043 shares of company stock worth $3,791,486. 0.30% of the stock is owned by insiders.

CME Group Stock Up 0.1%

Shares of NASDAQ:CME opened at $268.00 on Thursday. The stock’s 50-day moving average price is $265.57 and its two-hundred day moving average price is $272.19. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 12-month low of $213.94 and a 12-month high of $290.79. The firm has a market cap of $96.64 billion, a price-to-earnings ratio of 25.97, a PEG ratio of 4.41 and a beta of 0.38.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.63 by $0.05. CME Group had a return on equity of 14.61% and a net margin of 58.84%.The firm had revenue of $1.54 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same period last year, the company earned $2.68 EPS. The firm’s quarterly revenue was down 3.0% on a year-over-year basis. On average, research analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.